alexa Effects of Conjugated Linoleic Acid and Hilsha Fish Oil (Tenualosa Ilisha) on Alloxan Induced Diabetes Mellitus in Sprague Dawley Rats | Open Access Journals
ISSN: 2155-6156
Journal of Diabetes & Metabolism
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Effects of Conjugated Linoleic Acid and Hilsha Fish Oil (Tenualosa Ilisha) on Alloxan Induced Diabetes Mellitus in Sprague Dawley Rats

Islam Minarul1, Manirujjaman M1, Khan MMH1, Rahman Matiar1, Amin M Ziaul2, Uddin AMM1, Biswas Shahangir1 and Islam MA1*

1Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi-6205, Bangladesh

2Department of Biotechnology and Genetic Engineering, Jessore University of Science and Technology, Jessore, Bangladesh

*Corresponding Author:
Mohammad Amirul Islam Ph.D
M.Sc. (Biochemistry), Professor
Department of Biochemistry and Molecular Biology
University of Rajshahi, Rajshahi-6205, Bangladesh
Tel: + 880-171-2141273
Fax: + 880-721-750064
E-mail: [email protected]

Received date: May 13, 2014; Accepted date: July 27, 2014; Published date: August 18, 2014

Citation: Minarul I, Manirujjaman M, Khan MMH, Matiar R, Ziaul AM, et al. (2014) Effects of Conjugated Linoleic Acid and Hilsha Fish Oil (Tenualosa Ilisha) on Alloxan Induced Diabetes Mellitus in Sprague Dawley Rats. J Diabetes Metab 5:412 doi: 10.4172/2155-6156.1000412

Copyright: © 2014 Minarul I, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Diabetes & Metabolism


Diabetes mellitus is a multifarious disease. There is no specific cause for the development of this disease. Fish oil plays important role for the remediation of diabetes mellitus. Conjugated Linoleic Acid (CLA) was synthesized by five steps that included saponification of soybean oil, low temperature crystallization of saturated fatty acid, urea crystallization of oleic acid, alkali isomerization of linoleic acid to CLA and fatty acid analysis. Fish oil was extracted from sun dried fish flesh by n-hexane. The rats were divided into five groups. The Group-1 and Group-2 considered as normal and Diabetic Control. Group-3, Group-4 and Group-5 diabetic rats were treated with CLA, Fish oil and Glibenclamide respectively. Diabetes Mellitus (DM) was induced by single intra peritoneal injection of freshly prepared alloxan hydrate (55 mg/kg Body Weight of rat) in 0.9% saline solution. The significant effects (P<0.001) of CLA and fish oil were observed in alloxan-induced diabetic rats to control the blood glucose level within range. Antilipidemic effects of CLA and fish oil were also observed and found to reduce the cholesterol and LDL level whereas increased the HDL level significantly (P<0.05). Like glibenclamide CLA and fish oil had significant effects on the control of alloxan induced diabetes mellitus in Sprague Dawley rats.


Alloxan; CLA; Diabetic control; Glibenclamide; Hilsha fish


Fish is an essential and irreplaceable food in the rural Bangladeshi diet. Fish play an important role in the Bangladeshi diet, constituting the main and often irreplaceable animal source food in poor rural households [1]. Fish oil contain long chain polyunsaturated fatty acids more specifically Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) which have a great benefit for cardiac health, controlling blood glucose, reduction of arterial disease, lowering the risk of cancer etc. [2-25]. Diabetes mellitus is a group of metabolic disease characterized by high blood glucose, that results from absolute or relative deficiencies of insulin secretion which causes damage to the large blood vessels of the heart, brain and legs (macrovascular complications) and damage to the small blood vessels, causing problems in the eyes, kidneys, feet and nerves (microvascular complications) [26]. World Health Organization (WHO) published estimates that the diabetic population is likely to increase to 300 million or more by the year of 2025. The reason behind this is the adverse effect of all antidiabetic drugs during long term use [27]. Tenualosa ilisha is the national fish of Bangladesh and contributes both to national economy and health. CLA have the antidiabetic effect by mediating insulin release through islet G protein-coupled receptor FFA1/GPR40 [28]. The objectives of this study were to investigate and compare the effects of linoleic acids, extracted from soybean, and hilsha fish (Tenualosa ilisha) to standard glibenclamide on alloxan induced diabetes mellitus in Sprague Dawley rats.

Materials and Methods

Tenualosa ilisha is essentially a marine water fish but it is abundantly caught in the big and small rivers during July to April. After collection the fish materials were cut into small pieces and sun dried.

Extraction and purification of oil

Oil was extracted from the dried fish material with n-hexane by Soxhlet apparatus and the extracted oil was evaporated under reduced pressure in a rotatory evaporator to obtain oil. The isolated oil was purified by n-hexane fractionation method.

Animal maintenance

Sprague Dawley Rats weighing about 100-150 g were used for experiment. All the animals were kept and maintained under laboratory conditions of temperature (22 ± 2ºC) and 12 h day: 12 h night cycle. They were also allowed to free access of food (standard pellet diet) and water ad libitum. The animals were divided into five groups containing six rats in each group.

Induction of diabetes in rats

Diabetes mellitus was induced by single intraperitoneal injection of freshly prepared Alloxan Hydrate (55 mg/kg body weight) in 0.9% saline solution. Diabetes was developed and stabilized in these alloxan treated rats over a period of 48 hours. After three days of alloxan administration blood was collected by tail puncture and plasma glucose levels of each rat were determined. Rats with a fasting plasma glucose range of 280-350 mg/dL were considered diabetic and included in the study.

Treatment schedule

In experiment, the total number of 30 rats (6 normal; 24 Alloxandiabetic surviving rats) were used. The rats were divided into 5 groups of 6 rats in each group. Group 1 – normal rats treated with vehicle alone (Normal diet). Alloxan induced diabetic rats of Group 2, 3 and 4 were treated with conjugated linoleic acid (1% of total diet); hilsha fish oil (1% of total diet) and glibenclamide (0.6 mg/kg body weight) respectively. Group 5 alloxan-treated diabetic rats were controlled (normal diet) for 15 days.

Sample collection and assessment of serum

After 15 days of treatment blood specimens were collected from the thoracic artery of the rats after anaesthetization with diethyl ether. For coagulation, blood was kept about 20 minutes at room temperature. After centrifugation at 1600 g for 15 minutes at 4ºC, serum were drawn off and stored at -80°C until the experiments were performed.

Laboratory examination

The analyzer (CHEM-5 V3, Erba, Mannheim, Germany) were used for the measurement of serum indices by using commercially available kits according to the manufacture’s protocol. Cholesterol, HDL, LDL, triglycerides, urea, uric acid, creatinine, SGPT and SGOT level were measured by the kits from Human, Germany. All serum samples were analyzed in duplicate and then mean values were taken.

Statistical analysis

All the results were expressed as mean ± SEM. Difference between the groups were tested statistically by using independent t-test at 95% confidence interval. P<0.05 was considered as significant.


Hypoglycemic effect CLA and T.ilisha

Comparing the blood sugar level in alloxan induced rats, CLA and fish oil administered subject showed significant reduction of blood glucose level at P<0.001, which is as near as glibenclamide administered subject at P<0.001 (Table 1).

Group 3rd day 9th day 14th Day
Normal 91.19 ± 0.320 91.62 ± 0.3160 97.103 ± 0.5894
Diabetic Control 342.92 ± 1.478* 383.13  ±1.365* 393.36 ±1.433*
Diabetic+CLA 333.13 ± 1.90b** 325.81 ± 2.91** 329.95 ± 5.07**
Diabetic+Fish oil 322.86 ± 2.145a** 328.43 ± 3.290** 335.85  ± 3.47**
Diabetic+Glybenclemide 294.16 ± 4.400** 310.21 ± 1.949** 314.40  ± 3.98**

Table 1: Effect of CLA and T.ilisha fish oil on the blood glucose level of experimental rats.

Changes in Rat Body weight

In case of T.ilisha fish oil, the increase in body weight was 43.50%, which was highly significant (P<0.005) than the CLA treatment in which case body weight reduction was 32.81% (P<0.005). Increase of body weight by T.ilisha fish oil was as near as the glibenclamide treatment (44.63%, P<0.0001) (Table 2).

Group Initial After 7th day After 15th day
Normal 116.42 ± 0.51388 121.99 ± 0.7011 128.20 ± 0.966
Diabetic control 116.0 ±1.37246* 89.37 ± 1.1302a* 72.56 ± 2.18a*
Diabetic+CLA 117.14 ±1.4376** 86.23 ± 2.5238c** 96.37 ± 1.9042b**
Diabetic+Fish oil 116.77 ± 1.5242** 93.21 ± 3.707c** 104.13 ± 2.93b**
Diabetic+glibenclemide 111.81 ± 0.5753** 90.28 ± 1.445a** 104.95 ± 2.509a**

Table 2: Effect of CLA and T.ilisha fish oil on rats’ body weight

Lipid profile

18% and 21% reduction of cholesterol (P<0.01) level were observed for CLA and fish oil treatment respectively in diabetic rats whereas in case of glibenclamide, it was 32.64%. LDL level was reduced (P<0.05) for CLA, fish oil and glibenclamide treatment at 16.38%, 19.36% and 23.19% whereas HDL level was increased significantly (P<0.05) at 23.81%, 36.92% and 45.45% respectively. A little bit different scenario was observed for triglyceride level. Glibenclamide reduced the triglyceride level more significantly (38.28%, P<0.005) than CLA (16.47%, P<0.05) and fish oil (10.94%, P<0.05). Table 3 represented the change of lipid profile by the administration of CLA, fish oil and glibenclamide in alloxan induced diabetic rats (Table 3).

Group Cholesterol Triglycerides HDL LDL
Normal 67.88 ± 0.9612 71.88 ± 2.442 49.76 ± 1.051 84.006 ± 2.438
Diabetic Control 95.53 ± 1.963a* 108.15 ± 3.37b* 43.25 ± 1.944d* 119.79 ± 4.350b*
Diabetic+CLA 78.95 ± 1.604b** 90.33±2.069d** 53.55±0.5456c** 100.25±5.004d**
Diabetic+Fish oil 75.50 ± 2.516c** 97.02±1.385d** 59.22±1.366b** 96.59±4.588d**
Diabetic+Glibenclemide 64.34 ± 1.818a** 66.74±3.583b** 62.91±3.209c** 92.01±2.712c**

Table 3: Effect of CLA and T. ilisha fish oil on serum Cholesterol, Triglycerides, HDL and LDL on control and experimental rats (mean ± SEM).

Urea, Uric acid, Creatinine, SGPT and SGOT level

Urea, uric acid and creatinine level were increased significantly (P<0.05) after diabetic induction. Like glibenclamide, treatment of CLA and fish oil reduced urea level significantly (P<0.05). Significant reduction (P<0.05) of uric acid and creatinine level was also occurred after CLA and fish oil treatment (Table 4).

Treatment Group Uric Acid (mg/dl) Urea (mg/dl) Creatinine (mg/dl)
Normal 8.036 ± 0.3514 31.94 ± 1.7808 1.15 ± 0.09615
Dibetic Control 16.243 ± 0.962a* 55.16 ± 3.0162a* 2.55 ± 0.2826*
Diabetic+CLA 10.58 ± 0.6904** 42.23 ± 2.3531** 1.63 ± 0.01767**
Diabetic+Fish oil 11.626 ± 0.6688** 45.07 ± 1.4975** 1.54 ± 0.15560**
Diabetic+Glibenclemide 9.69 ± 0.3626** 34.41 ± 2.6469a** 1.00 ± 0.2343**

Table 4: Effect of CLA and T. ilisha fish oil on serum Uric acid, Urea and cretinine on control and experimental rats (mean ± SEM).

There was a significant (P<0.001) increase of SGPT and SGOT level after diabetes induction which was compensated by CLA and fish oil significantly (P<0.001). The reduction of SGPT by CLA and fish oil was 29.84% and 30.99% respectively whereas 42.22% for glibenclamide. The reduction of SGOT level was highly significant for fish oil (50.05%) than CLA and glibenclamide (11.82% and 20.98% respectively) (Table 5).

Normal 112.90 ± 2.771 219.93 ± 1.66
Diabetic control 268.65 ± 5.705* 273.35 ± 6.08a*
Diabetic+CLA 188.47 ± 3.349** 241.04 ± 1.35a**
Diabetic+Fish oil 185.37 ± 3.41** 136.50 ± 2.02**
Diabetic+Glibenclemide 155.06 ± 2.93** 216.00 ± 2.94**

Table 5: Effect of CLA and T.ilisha fish oil on serum SGPT and SGOT of experimental rats.


Worldwide diabetes mellitus is a common disease; millions of peoples are affected by diabetes. It is a chronic metabolic disorder [29]. The main aim of our study was to estimate the antidiabetic effect of conjugated linoleic acid (CLA) and hilsha fish oil (Tenualosa ilisha) in alloxan induced diabetic rats. Alloxan is a chemical agent which induces diabetes by the destruction of pancreatic beta cells. Low dose (55 mg/kg body weight) administation of alloxan causes incomplete destruction of beta cells even though the rats become permanently diabetic [30].

Our present study showed that oral administration of CLA and fish oil decreased blood glucose levels significantly in treated diabetic rats compared with the controlled diabetic rats (P<0.001). The hypoglycemic effect of CLA and fish oil resulted from the enhancement of the production of insulin from the existing beta cells of islets of Langerhans or CLA and fish oil might increase the peripheral uptake of glucose [31]. The plasma glucose lowering activity was compared with glibenclamide, a standard hypoglycemic drug. Glibenclamide had been used for many years to treat diabetes, to stimulate insulin secretion from pancreatic beta cells [32].

The serum glucose data that have obtained clearly indicate that the oral administration of CLA and fish oil produced significant hypoglycemic effect in alloxan induced diabetic rats compared with alloxan induced diabetic control rats.

The results also indicated that CLA and fish oil was more beneficial in the treatment of diabetes as it had hypolipidemic effect. Their hypolipidemic effect could represent a protective mechanism against the development of atherosclerosis, which is usually associated with diabetes.

In our experiment the cholesterol level in CLA, fish oil and glibenclamide treated rats were lower than alloxan induced diabetic control rats. HDL level was significantly increased (P<0.01) following a significant decrease in LDL level (P<0.05) which is an indication of the reduction of the risk of coronary heart diseases that are very common in diabetic patient [33].

The SGOT and SGPT level was increased in diabetic patient as an indication of the liver damage that back to their respective normal level after treatment with CLA, fish oil and glibenclamide that further strengthen the antidiabetic effect of CLA and fish oil. The low level of SGOT and SGPT in CLA and fish oil consuming diabetic rats comparing to control rats indicated the normal function of liver.

Increased serum urea and creatinine levels are significant markers of renal dysfunction in diabetic hyperglycemia which also corrected by the CLA and fish oil treatment in the alloxan induced diabetic rats (P<0.05). This result represented the improved renal function than the diabetic control rats.

From the above discussion we could suggest that Conjugated Linoleic Acid (CLA) and fish oil (Tenualosa ilisha) significantly exert hypoglycemic and hypolipidemic effect on alloxan induced diabetic rats. This investigation showed that CLA and fish oil might contribute in the prevention of diabetes mellitus if used as dietary supplement.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Article Usage

  • Total views: 11600
  • [From(publication date):
    August-2014 - Jun 28, 2017]
  • Breakdown by view type
  • HTML page views : 7819
  • PDF downloads :3781

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version